Smoking Cessation and Relapse Prevention in Women Postpartum (EARLINT-EP3)

This study has been completed.
Sponsor:
Collaborator:
German Federal Ministry of Education and Research
Information provided by:
University Medicine Greifswald
ClinicalTrials.gov Identifier:
NCT00475046
First received: May 16, 2007
Last updated: May 18, 2007
Last verified: May 2007
  Purpose

Background: Pregnancy was found to be a significant triggering factor for smoking cessation and the reduction of nicotine consumption, but 50 - 70 % of mothers who stopped smoking during pregnancy resume tobacco smoking after delivery. One main reason for the high relapse rates is that many women are solely motivated to quit smoking for the baby’s sake. After birth, the external reason for having quit has vanished and no other internal or external motives exist for many women to maintain being smoke-free. Therefore, under consideration of the Transtheoretical Model approach, relapse prevention and smoking cessation interventions have to focus on two aspects: (1) on a specific reformulation of the stages of change for women who show a temporarily and externally motivated change in smoking behavior during pregnancy, (2) on intervention strategies taking advantage of the behavioral change already done and evoking the cognitive and behavioral processes necessary for maintenance. In Germany pediatricians are in a unique position to address this issue because nearly every mother attends a pediatric practice for preventive examination of the newborn. Objectives: To adapt and implement motivational enhancement interventions in pediatric practices. The aim is to examine the effectiveness of a modified stage-matched motivational enhancement intervention added to the common pediatricians´ advice. A second aim is the reformulation and reassessment of the stages of change for women who have recently given birth. Methods: The study design is a randomized controlled trial. Mothers smoking at the beginning of the pregnancy and attending pediatric practices in West Pomerania will be assigned to an intervention group (n = 330) and referred to a liaisonal service providing a face-to-face motivational enhancement intervention followed by telephone brush-up sessions. A control group (n = 330) receives treatment from the pediatrician as usual at the preventive examination. The core outcome measures comprise abstinence, and progress in the stages of change 6, 12, 18 and 24 months after baseline. Expected impact: Data will evaluate the usefulness of intervening in pediatric offices and will provide information about a tailored intervention program. The processes of change favorable for intervention in this population will be identified. This is of great relevance with regard to the prevention of health damage for mother and child. Furthermore, results will serve as a basis for guidelines for pediatricians to deal with women smoking postpartum. Relationship to the objective of the collaboration: As in the other studies, this study provides empirical data of a new proactive approach to reach underserved populations in the addiction field. This project will add knowledge on how to intervene (motivational enhancement vs. usual advice), on setting-specific advantages of pediatric offices and on the impact of the chosen intervention strategy.


Condition Intervention Phase
Smoking Cessation
Behavioral: Motivational Interviewing
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Smoking Cessation and Relapse Prevention in Women Postpartum

Resource links provided by NLM:


Further study details as provided by University Medicine Greifswald:

Primary Outcome Measures:
  • Current and sustained smoking abstinence prevalence, amount of cigarettes smoked per day [ Time Frame: 6, 12, 18 and 24 monthy after baseline ]

Secondary Outcome Measures:
  • Adapted Transtheoretical Model core constructs [ Time Frame: 6, 12, 18 and 24 monthy after baseline ]

Enrollment: 2790
Study Start Date: October 2001
Study Completion Date: May 2005
  Show Detailed Description

  Eligibility

Ages Eligible for Study:   1 Year and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Every mother presenting her newborn for the first time in the pediatric practices will be screened. Of these, all women smoking at the date the female received verification of her pregnancy are eligible for the study.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00475046

Sponsors and Collaborators
University Medicine Greifswald
German Federal Ministry of Education and Research
Investigators
Principal Investigator: Ulfert Hapke, PhD Institut für Epidemiologie und Sozialmedizin, University of Greifswald
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00475046     History of Changes
Other Study ID Numbers: 01EB0120-TP3
Study First Received: May 16, 2007
Last Updated: May 18, 2007
Health Authority: Germany: Federal Ministry of Education and Research

Keywords provided by University Medicine Greifswald:
smoking
post partum
relapse prevention
motivational interviewing
TTM
implement motivational enhancement interventions in pediatric practices
examine the effectiveness of the intervention
develop measurements appropriate to tailor interventions
analyze further unfavorable and favorable factors outlined by previous research

Additional relevant MeSH terms:
Smoking
Habits

ClinicalTrials.gov processed this record on July 10, 2014